“novo-ventures” Archives

in
Entry Author Date Location
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
Rgenix Secures $33,000,000 Series B Funding 06/16/16 New York
Entasis Therapeutics Garners $50,000,000 Series B Funding 04/05/16 Boston
AstraZeneca Spinout Entasis Snags $50M For Anti-Infective Treatments 04/04/16 Boston
Outpost Medicine Obtains $41,000,000 New Funding 03/16/16 San Francisco
Unchained Labs Obtains $25,000,000 Series B Funding 03/02/16 San Francisco
Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug 01/27/16 Boston
Tarveda Therapeutics Garners $38,000,000 Series C Funding Round 01/27/16 Boston
Corvus Pharmaceuticals Receives $75,000,000 Series B Funding 09/30/15 San Francisco
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
KalVista Pharmaceuticals Lands $33,000,000 Series B Funding 07/23/15 Boston
Ra Pharmaceuticals Receives $58,500,000 Series B Round 07/23/15 Boston
AnaptysBio Receives $40,000,000 Series D Funding 07/16/15 San Diego
Nuvelution Pharma Secures New Funding 07/14/15 San Francisco
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
Unchained Labs Grabs $25M and New Device to Test Stability of Proteins 02/12/15 San Francisco
Migraine Drug Developer CoLucid Lands $37.1M for Phase 3 Trial 01/13/15 Raleigh Durham
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
Otonomy Raises $49M to Advance 3 Drugs for Treating Ear Diseases 04/30/14 San Diego
ZS Pharma Secures $55,000,000 Series D Financing Round 03/06/14 Texas
San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More 02/28/14 San Diego
Thesan Pharmaceuticals Secures $49,000,000 Series B Financing 02/25/14 San Diego
San Diego Life Sciences Roundup: Evoke Pharma, Isis, Otonomy, & More 09/06/13 San Diego
Otonomy Garners Series C Funding Round 09/04/13 San Diego
Ceterix Comes Out With Tool to Repair, Not Remove, Knee Cartilage 07/16/13 San Francisco
Ophthotech Nabs $175M To Fund Late-Stage Trial For Eye Drug 05/29/13 New York
Cardeas Pharma Secures $34,000,000 Series B Funding Round 05/23/13 Seattle
Nevro Obtains $48,000,000 Series C Funding Round 03/07/13 San Francisco
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Page 1 of 2 next page »